Laurie Keating - Net Worth and Insider Trading
Laurie Keating Net Worth
The estimated net worth of Laurie Keating is at least $2 Million dollars as of 2024-11-10. Laurie Keating is the EVP, Chief Legal Officer of Alnylam Pharmaceuticals Inc and owns about 5,566 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $2 Million. Laurie Keating is the SVP, GC & Secretary of Alkermes PLC and owns about 11,757 shares of Alkermes PLC (ALKS) stock worth over $339,307. Laurie Keating is also the Director of Immuneering Corp and owns about 14,000 shares of Immuneering Corp (IMRX) stock worth over $26,600. Besides these, Laurie Keating also holds PepGen Inc (PEPG) . Details can be seen in Laurie Keating's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Laurie Keating has not made any transactions after 2022-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Laurie Keating
Laurie Keating Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laurie Keating owns 4 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Imago BioSciences Inc (IMGO) , and Immuneering Corp (IMRX) among others .
Click here to see the complete history of Laurie Keating’s form 4 insider trades.
Insider Ownership Summary of Laurie Keating
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2021-08-05 | SVP,GC & Secretary |
| IMGO | Imago BioSciences Inc | 2021-11-17 | director |
| IMRX | Immuneering Corp | 2022-05-16 | director |
 | | 2022-05-06 | director |
Laurie Keating Latest Holdings Summary
Laurie Keating currently owns a total of 4 stocks. Among these stocks, Laurie Keating owns 5,566 shares of Alnylam Pharmaceuticals Inc (ALNY) as of August 5, 2021, with a value of $2 Million and a weighting of 79.97%. Laurie Keating owns 11,757 shares of Alkermes PLC (ALKS) as of December 20, 2017, with a value of $339,307 and a weighting of 17.57%. Laurie Keating also owns 14,000 shares of Immuneering Corp (IMRX) as of May 16, 2022, with a value of $26,600 and a weighting of 1.38%. The other 1 stocks PepGen Inc (PEPG) have a combined weighting of 1.08% among all his current holdings.
Latest Holdings of Laurie Keating
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2021-08-05 | 5,566 | 277.43 | 1,544,175 |
| ALKS | Alkermes PLC | 2017-12-20 | 11,757 | 28.86 | 339,307 |
| IMRX | Immuneering Corp | 2022-05-16 | 14,000 | 1.90 | 26,600 |
| PEPG | PepGen Inc | 2022-05-06 | 4,166 | 5.01 | 20,872 |
Holding Weightings of Laurie Keating
Laurie Keating Form 4 Trading Tracker
According to the SEC Form 4 filings, Laurie Keating has made a total of 10 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 10,000 shares on August 5, 2021, which brought Laurie Keating around $2 Million.
According to the SEC Form 4 filings, Laurie Keating has made a total of 0 transactions in Alkermes PLC (ALKS) over the past 5 years. The most-recent trade in Alkermes PLC is the sale of 6,249 shares on December 20, 2017, which brought Laurie Keating around $757,379.
According to the SEC Form 4 filings, Laurie Keating has made a total of 2 transactions in Immuneering Corp (IMRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Immuneering Corp is the acquisition of 7,000 shares on May 16, 2022, which cost Laurie Keating around $35,000.
More details on Laurie Keating's insider transactions can be found in the Insider Trading History of Laurie Keating table.Insider Trading History of Laurie Keating
- 1
Laurie Keating Trading Performance
GuruFocus tracks the stock performance after each of Laurie Keating's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laurie Keating is 31.64%. GuruFocus also compares Laurie Keating's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laurie Keating within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Laurie Keating's insider trading performs compared to the benchmark.
Performance of Laurie Keating
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.42 | | | | | |
| Relative Return to S&P 500(%) | 13.82 | | | | | |
Laurie Keating Ownership Network
Ownership Network List of Laurie Keating
Ownership Network Relation of Laurie Keating
Laurie Keating Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Laurie Keating is the SVP,GC & Secretary of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Laurie Keating made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 52,531 shares made by Yvonne Greenstreet , a net sale of 10,304 shares made by Pushkal Garg , and a net sale of 5,639 shares made by Jeffrey V. Poulton .
In summary, during the past 3 months, insiders sold 37,025 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 37,025 shares. During the past 18 months, 249,128 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 249,128 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Laurie Keating Mailing Address
Above is the net worth, insider trading, and ownership report for Laurie Keating. You might contact Laurie Keating via mailing address: 300 Third Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
